- Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q2 EPS of -$0.10
- Revenue of $0.3M (-14.3% Y/Y)
- Press Release
Cyclacel Pharmaceuticals reports Q2 results
Recommended For You
More Trending News
About CYCC Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| CYCC | - | - |
| Cyclacel Pharmaceuticals, Inc. | ||